Biomarin Pharmaceutical Inc

Susquehanna Portfolio Strategies, LLC BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

53,419

Value ($000)

3,175

Weight

0.0%

2023 Q4 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,175	0.0%	53,419	12/31/2025
2025 Q3	11/14/2025	12,589	0.2%	232,447	9/30/2025
2025 Q2	8/14/2025	6,614	0.1%	120,319	6/30/2025
2025 Q1	5/14/2025	1,334	0.6%	18,868	3/31/2025
2024 Q1	5/7/2024	3,489	0.1%	39,949	3/31/2024
2023 Q4	2/14/2024	19,543	0.3%	202,685	12/31/2023